pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
intensity-modulated radiation therapy
Phase 3 · other · Breast Cancer
intensity-modulated radiation therapy for Breast Cancer is a Phase 3 program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Internal code CDR0000629770
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- United Therapeutics Europe Ltd
- Phase
- Phase 3
- Modality
- other
- Indication
- Breast Cancer
- Status
- active
- Trials
- 1